Frederick, MD, United States of America

Mohamed Diwan M Abdulhameed


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Liver Diagnostics: The Contributions of Mohamed Diwan M Abdulhameed

Introduction

Mohamed Diwan M Abdulhameed, based in Frederick, MD, is a notable inventor with a strong focus on medical innovations. With a unique patent that addresses critical health issues related to liver fibrosis, Abdulhameed's work paves the way for enhanced diagnostics and therapeutic measures.

Latest Patents

Abdulhameed holds a patent titled "Articles for diagnosis of liver fibrosis." This innovative patent discloses various methods and articles, such as gene arrays and antibodies, that are instrumental in determining the progression or regression of liver fibrosis. Furthermore, his invention plays a crucial role in the diagnosis of liver diseases and screening compounds for hepatotoxicity and efficacy against liver fibrosis. The related therapeutic methods presented in the patent promise to enhance treatment options for patients suffering from liver-related ailments.

Career Highlights

Mohamed Diwan M Abdulhameed's professional journey is marked by his association with the Government of the United States, as represented by the Secretary of the Army. In this role, he contributes significantly to advancements in medical research and diagnostics, leveraging his expertise to benefit public health.

Collaborations

Throughout his career, Abdulhameed has collaborated with esteemed professionals such as Gregory J Tawa and Danielle L Ippolito. These collaborations have further enriched his research endeavors, fostering innovation in the area of liver diagnostics and treatments.

Conclusion

In summary, Mohamed Diwan M Abdulhameed stands out as a significant figure in the field of medical innovation. His patent on liver fibrosis diagnosis not only advances medical science but also has the potential to improve patient outcomes significantly. With ongoing collaborations and his commitment to research, Abdulhameed is poised to make even more impactful contributions in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…